Form 4: Codexis Director Acquires Stock Options

Cynthia Collins, a Director at Codexis, Inc., acquired stock options granting the right to buy 66,350 shares.

Summary

• Cynthia Collins, a Director of Codexis, Inc., was granted stock options on June 17, 2026.
• These options provide the right to purchase 66,350 shares of common stock.
• The exercise price for these options is $2.48 per share.
• The options vest and become exercisable on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, provided Ms. Collins continues to serve as a director.
• The expiration date for these options is June 17, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard stock option grant to a director rather than a new investment or a sale of shares.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The grant of options aligns the director's interests with those of shareholders.
• The exercise price of $2.48 suggests a potential for upside if the stock price increases significantly.

Negatives

• This is a grant of options, not a purchase of stock, meaning no immediate capital is invested by the director.
• The vesting schedule means the director must remain with the company for a period before realizing the full benefit of the options.

Risks

• The value of the options is entirely dependent on the future stock price of Codexis, Inc.
• If the stock price does not exceed the exercise price of $2.48 plus any associated costs, the options may expire worthless.

Future Outlook

The future outlook for the options is contingent on the company's stock performance, as they are exercisable at $2.48 per share and vest over time.

Industry Context

StockSavvy.ai notes that grants of stock options to directors are a common practice in the biotechnology and pharmaceutical sectors, aiming to incentivize long-term performance and align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant of options aligns director incentives with shareholder interests, potentially leading to decisions that enhance stock value. However, it does not represent immediate dilution.
• Employees: Standard practice that does not directly impact employees.
• Management: Reinforces standard compensation and incentive structures.

Next Steps

• The stock options will vest according to the schedule outlined.
• Cynthia Collins may choose to exercise the options if the stock price is above the exercise price of $2.48 after vesting.

Key Dates

Keywords

Codexis, CDXS, Form 4, Stock Options, Director, Beneficial Ownership, Securities Exchange Act, SEC Filing